Financhill
Back

Recursion Pharmaceuticals Vs. Palatin Technologies Industry Stock Comparison

Sell
44

RXRX
Recursion Pharmaceuticals

Last Price:
5.70
Seasonality Move:
6.36%
Sell
40

PTN
Palatin Technologies

Last Price:
0.96
Seasonality Move:
16.84%
Sell
44
Recursion Pharmaceuticals (RXRX) is a Sell

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $5.75. The Score for RXRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Palatin Technologies (PTN) is a Sell

Is Palatin Technologies a Buy, Sell or Hold?

  • The current Palatin Technologies [PTN] share price is $0.94. The Score for PTN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PTN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $5.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight selling pressure.

PTN Stock Price Chart

What is Palatin Technologies's stock price today?

  • The Palatin Technologies share price today is $0.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTN is experiencing slight selling pressure.

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 37.1 Sell
Chaikin Money Flow: -4487806 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.21 - 7.15) Sell
Bollinger Bands (100): (6.27 - 7.63) Sell

PTN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 39.52 Sell
Chaikin Money Flow: 179 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.99 - 1.21) Sell
Bollinger Bands (100): (1.02 - 1.64) Sell

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.52 Sell
20-day SMA: 6.7 Sell
50-day SMA: 6.63 Sell
200-day SMA: 8.34 Sell
8-day EMA: 6.34 Sell
20-day EMA: 6.58 Sell
50-day EMA: 6.71 Sell
200-day EMA: 7.7 Sell

PTN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.02 Sell
20-day SMA: 1.12 Sell
50-day SMA: 1.06 Sell
200-day SMA: 1.72 Sell
8-day EMA: 1 Sell
20-day EMA: 1.06 Sell
50-day EMA: 1.13 Sell
200-day EMA: 1.66 Sell

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.

Palatin Technologies Earnings Growth & PTN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.85 per share.

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Palatin Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):